share_log

UnitedHealth | 10-Q: Q2 2024 Earnings Report

UnitedHealth | 10-Q: Q2 2024 Earnings Report

联合健康 | 10-Q:2024财年二季报
美股SEC公告 ·  2024/08/09 16:15

Moomoo AI 已提取核心信息

UnitedHealth Group reported Q2 2024 revenues of $98.9 billion, up 6% year-over-year, with consolidated earnings from operations of $7.9 billion compared to $8.1 billion in Q2 2023. The quarter was impacted by the Change Healthcare cyberattack, resulting in $776 million in direct response costs and $334 million in business disruption impacts at Optum Insight.UnitedHealthcare revenues grew 5% to $73.9 billion, serving 1.6 million more people domestically, though earnings declined 8% to $4 billion due to Medicare Advantage funding reductions and cyberattack-related costs. Optum revenues increased 12% to $62.9 billion, with Optum Health up 13% and Optum Rx up 13%, while Optum Insight revenue decreased 3% due to cyberattack disruptions.The company recorded a $1.2 billion loss related to South American subsidiaries held for sale in Q2, including $867 million in foreign currency translation losses. Medical care ratio increased to 85.1% from 83.2% last year. The company maintained its strong liquidity position with $26.3 billion in cash and cash equivalents as of June 30, 2024.
UnitedHealth Group reported Q2 2024 revenues of $98.9 billion, up 6% year-over-year, with consolidated earnings from operations of $7.9 billion compared to $8.1 billion in Q2 2023. The quarter was impacted by the Change Healthcare cyberattack, resulting in $776 million in direct response costs and $334 million in business disruption impacts at Optum Insight.UnitedHealthcare revenues grew 5% to $73.9 billion, serving 1.6 million more people domestically, though earnings declined 8% to $4 billion due to Medicare Advantage funding reductions and cyberattack-related costs. Optum revenues increased 12% to $62.9 billion, with Optum Health up 13% and Optum Rx up 13%, while Optum Insight revenue decreased 3% due to cyberattack disruptions.The company recorded a $1.2 billion loss related to South American subsidiaries held for sale in Q2, including $867 million in foreign currency translation losses. Medical care ratio increased to 85.1% from 83.2% last year. The company maintained its strong liquidity position with $26.3 billion in cash and cash equivalents as of June 30, 2024.
联合健康集团报告2024年第二季度营业收入为989亿,同比增长6%,运营合并收益为79亿,而2023年第二季度为81亿。本季度受到Change Healthcare网络攻击的影响,导致直接响应成本达到77600万,Optum Insight的业务中断影响为33400万。联合健康的营业收入增长5%,达到739亿,服务国内多了160万人,但由于医疗保险优先计划资金削减和网络攻击相关费用,收益下降8%,为40亿。Optum的营业收入增长12%,达到629亿,Optum Health增长13%,Optum Rx增长13%,而由于网络攻击导致的中断,Optum Insight的营业收入下降3%。该公司在第二季度录得与待售南美子公司相关的12亿损失,包括86700万的外汇翻译损失。医疗保健比率从去年的83.2%上升至85.1%。截至2024年6月30日,该公司保持强劲的流动性,现金及现金等价物为263亿。
联合健康集团报告2024年第二季度营业收入为989亿,同比增长6%,运营合并收益为79亿,而2023年第二季度为81亿。本季度受到Change Healthcare网络攻击的影响,导致直接响应成本达到77600万,Optum Insight的业务中断影响为33400万。联合健康的营业收入增长5%,达到739亿,服务国内多了160万人,但由于医疗保险优先计划资金削减和网络攻击相关费用,收益下降8%,为40亿。Optum的营业收入增长12%,达到629亿,Optum Health增长13%,Optum Rx增长13%,而由于网络攻击导致的中断,Optum Insight的营业收入下降3%。该公司在第二季度录得与待售南美子公司相关的12亿损失,包括86700万的外汇翻译损失。医疗保健比率从去年的83.2%上升至85.1%。截至2024年6月30日,该公司保持强劲的流动性,现金及现金等价物为263亿。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息